Cell Growth & Differentiation, Vol 3, Issue 3 175-181, Copyright © 1992 by American Association of Cancer Research

ARTICLES

Anti-immunoglobulin treatment of murine B-cell lymphomas induces active transforming growth factor beta but pRB hypophosphorylation is transforming growth factor beta independent

GL Warner, JW Ludlow, DA Nelson, A Gaur and DW Scott
Division of Immunology and Immunotherapy, University of Rochester Cancer Center, New York 14642.

Cross-linking of B-cell membrane immunoglobulin (Ig) receptors induces growth arrest at G1-S, leading to apoptosis and cell death in the immature lymphomas WEHI-231 and CH31, but not in the CH12 B-cell line. In this system, which has been used as a model for B-cell tolerance, we have established that these lymphomas produce active transforming growth factor beta (TGF-beta) when treated with anti-Ig and that their hierarchy of sensitivity to TGF-beta generally correlates with their growth inhibition by anti-Ig. TGF-beta, in turn, has been shown to interfere with the phosphorylation of the retinoblastoma gene product, pRB. Herein, we also demonstrate that in WEHI-231 B-lymphoma cells treated with anti-Ig for 24 h, the pRB protein is found to be predominantly in the underphosphorylated form, as previously reported for cells arrested by the exogenous addition of TGF-beta. However, neutralizing antibodies to TGF-beta failed to prevent growth inhibition by anti-Ig in WEHI-231 and CH31. When WEHI-231 lymphoma cells were selected for growth in TGF-beta, the majority of the TGF-beta-resistant clones remained sensitive to anti-Ig-mediated growth inhibition. In these clones, the retinoblastoma gene product was found to be in the underphosphorylated form after 24-h treatment with anti-Ig, but not with TGF-beta. These data show that anti-Ig treatment of murine B-cell lymphomas stimulates the production of active TGF-beta but that a TGF-beta-independent pathway may be responsible for the pRB underphosphorylation and cell cycle blockade.

This article has been cited by other articles:

				M. Sakurai, T. Hayashi, K. Abe, Y. Itoyama, K. Tabayashi, and W. I. Rosenblum Cyclin D1 and Cdk4 Protein Induction in Motor Neurons After Transient Spinal Cord Ischemia in Rabbits Editorial Comment Stroke, January 1, 2000; 31(1): 200 - 207. [Abstract] [Full Text] [PDF]

				M. Wu, R. E. Bellas, J. Shen, W. Yang, and G. E. Sonenshein Increased p27Kip1 Cyclin-Dependent Kinase Inhibitor Gene Expression Following Anti-IgM Treatment Promotes Apoptosis of WEHI 231 B Cells J. Immunol., December 15, 1999; 163(12): 6530 - 6535. [Abstract] [Full Text] [PDF]

				T. L. Brown, S. Patil, C. D. Cianci, J. S. Morrow, and P. H. Howe Transforming Growth Factor beta Induces Caspase 3-independent Cleavage of alpha II-Spectrin (alpha -Fodrin) Coincident with Apoptosis J. Biol. Chem., August 13, 1999; 274(33): 23256 - 23262. [Abstract] [Full Text] [PDF]

				L. Genestier, S. Kasibhatla, T. Brunner, and D. R. Green Transforming Growth Factor beta 1 Inhibits Fas Ligand Expression and Subsequent Activation-induced Cell Death in T Cells via Downregulation of c-Myc J. Exp. Med., January 18, 1999; 189(2): 231 - 239. [Abstract] [Full Text] [PDF]

				M. Wu, R. E. Bellas, J. Shen, and G. E. Sonenshein Roles of the Tumor Suppressor p53 and the Cyclin-dependent Kinase Inhibitor p21WAF1/CIP1 in Receptor-mediated Apoptosis of WEHI 231 B Lymphoma Cells J. Exp. Med., May 18, 1998; 187(10): 1671 - 1679. [Abstract] [Full Text] [PDF]

				E. W.-F. Lam, M. S. K. Choi, J. van der Sman, S. A. Burbidge, and G. G. B. Klaus Modulation of E2F Activity via Signaling through Surface IgM and CD40 Receptors in WEHI-231 B Lymphoma Cells J. Biol. Chem., April 17, 1998; 273(16): 10051 - 10057. [Abstract] [Full Text] [PDF]

				H. Kamesaki, K. Nishizawa, G. Y. Michaud, J. Cossman, and T. Kiyono TGF-{beta}1 Induces the Cyclin-Dependent Kinase Inhibitor p27Kip1 mRNA and Protein in Murine B Cells J. Immunol., January 15, 1998; 160(2): 770 - 777. [Abstract] [Full Text] [PDF]

				S. R. Amoroso, N. Huang, A. B. Roberts, M. Potter, and J. J. Letterio Consistent loss of functional transforming growth factor beta  receptor expression in murine plasmacytomas PNAS, January 6, 1998; 95(1): 189 - 194. [Abstract] [Full Text] [PDF]

				M. C. Horne, K. L. Donaldson, G. L. Goolsby, D. Tran, M. Mulheisen, J. W. Hell, and A. F. Wahl Cyclin G2 Is Up-regulated during Growth Inhibition and B Cell Antigen Receptor-mediated Cell Cycle Arrest J. Biol. Chem., May 9, 1997; 272(19): 12650 - 12661. [Abstract] [Full Text] [PDF]

				C. Borner and C. Borner Diminished Cell Proliferation Associated with the Death-protective Activity of Bcl-2 J. Biol. Chem., May 31, 1996; 271(22): 12695 - 12698. [Abstract] [Full Text] [PDF]

				S. Patil, G. M. Wildey, T. L. Brown, L. Choy, R. Derynck, and P. H. Howe Smad7 Is Induced by CD40 and Protects WEHI 231 B-lymphocytes from Transforming Growth Factor-beta -induced Growth Inhibition and Apoptosis J. Biol. Chem., December 1, 2000; 275(49): 38363 - 38370. [Abstract] [Full Text] [PDF]